Berberine partially ameliorates cardiolipotoxicity in diabetic cardiomyopathy by modulating SIRT3‐mediated lipophagy to remodel lipid droplets homeostasis. - Chen, Wenxian; Jin, Tongzhu; Xie, Yilin; Zhong, Changsheng; Gao, Huiying; Zhang, Lei; Ju, Jin; Cheng, Ting; Li, Mengyang; Wang, Huifang; Yang, Zhenbo; Deng, Qin; et al. (British Journal of Pharmacology, 2025)